HC Wainwright & Co. sets $35.00 price target for BlossomHill
HC Wainwright & Co. announced a $35.00 per-share price target for BlossomHill Therapeutics, according to ratings actions
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.